MEG3 and chronic myelogenous leukemia, BCR-ABL1 positive: The data from this experiment further elucidated the mechanisms underlying the formation of drug-resistance CML cells, involving three key players: lncRNA MEG3, the regulatory miRNA miR-21, and ABC transporters.